Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Department of Head-neck Tumor & Lymphoma, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Virchows Arch. 2021 Aug;479(2):355-363. doi: 10.1007/s00428-021-03071-z. Epub 2021 Mar 1.
Follicular helper T-cell-derived peripheral T-cell lymphoma (TFH-derived PTCL) initially present in the Waldeyer's ring is a rare condition with a challenging diagnosis. This study aimed to evaluate the clinicopathological characteristics and diagnosis of Waldeyer's ring TFH-derived PTCL and raise awareness of this type of lymphoma. A series of 13 cases of Waldeyer's ring TFH-derived PTCL were retrospectively analyzed. Clinically, most patients presented with localized manifestations, such as painless cervical lymphadenopathy (7/13), pharyngalgia (6/13), and nasal obstruction (3/13), and systemic symptoms were uncommon. Macroscopically, plump mass (9/13) and nodular lesions (3/13) covered with intact and tense mucosa were the main findings on fiberoptic laryngoscopy examination. Pathologically, diffuse infiltration with atypical lymphocytes in the lamina propria (10/13) was the most common growth pattern. Clear cells (9/13) and vascular proliferation (11/13) within a polymorphic inflammatory background (11/13) were frequently observed. All cases expressed at least two TFH markers: PD-1 in 92.3% (12/13), BCL6 in 69.2% (9/13), CXCL13 in 53.8% (7/13), and CD10 in 46% (6/13). Targeted next-generation sequencing analysis identified frequent mutations, including TET2 (10/11), RHOA (6/11), DNMT3A (3/11), and IDH2 (2/11). The overall survival rate at 2 years was 35.5%, and survival analysis revealed that patients with localized disease showed better overall survival (P = 0.022). In conclusion, careful morphological observation combined with immunohistochemistry and molecular analysis would help in diagnosis of TFH-derived PTCL involving the Waldeyer's ring, which is a rare condition that frequently presents with atypical clinical manifestations.
生发中心辅助 T 细胞衍生的外周 T 细胞淋巴瘤(TFH 衍生的 PTCL)最初发生在瓦勒环,是一种罕见的疾病,诊断具有挑战性。本研究旨在评估瓦勒环 TFH 衍生的 PTCL 的临床病理特征和诊断,并提高对这种淋巴瘤的认识。回顾性分析了 13 例瓦勒环 TFH 衍生的 PTCL 病例。临床上,大多数患者表现为局部表现,如无痛性颈淋巴结病(7/13)、咽痛(6/13)和鼻塞(3/13),全身症状不常见。纤维喉镜检查主要发现为:固有层弥漫性浸润的异常淋巴细胞(10/13)、黏膜完整紧张的肥厚肿块(9/13)和结节状病变(3/13)。病理学上,以固有层弥漫性浸润的不典型淋巴细胞(10/13)为最常见的生长模式。在多形性炎症背景下(11/13)常观察到透明细胞(9/13)和血管增生(11/13)。所有病例均至少表达两种 TFH 标志物:PD-1(92.3%,12/13)、BCL6(69.2%,9/13)、CXCL13(53.8%,7/13)和 CD10(46%,6/13)。靶向下一代测序分析发现了频繁的突变,包括 TET2(10/11)、RHOA(6/11)、DNMT3A(3/11)和 IDH2(2/11)。2 年总生存率为 35.5%,生存分析显示局限性疾病患者的总生存率更好(P=0.022)。总之,仔细观察形态学表现,结合免疫组化和分子分析有助于诊断瓦勒环 TFH 衍生的 PTCL,这是一种罕见的疾病,常表现出非典型的临床表现。